Safety and immunogenicity of a primary series and booster dose of the meningococcal serogroup B-factor H binding protein vaccine (MenB-FHbp) in healthy children aged 1–9 years: two phase 2 randomised, controlled, observer-blinded studies-Reference-Cited by-同舟云学术

Safety and immunogenicity of a primary series and booster dose of the meningococcal serogroup B-factor H binding protein vaccine (MenB-FHbp) in healthy children aged 1–9 years: two phase 2 randomised, controlled, observer-blinded studies

Published:2023-01 Issue:1 Volume:23 Page:103-116
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Marshall Helen S,Vesikari Timo,Richmond Peter C,Wysocki Jacek,Szenborn Leszek,Beeslaar Johannes,Maguire Jason D,Balmer Paul,O'Neill Robert,Anderson Annaliesa S,Prégaldien Jean-Louis,Maansson Roger,Jiang Han-Qing,Perez John L

Funder

Children's Hospital Los Angeles

National Health and Medical Research Council

Pfizer

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference26 articles.

1. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP);Cohn;MMWR Recomm Rep,2013

2. Meningococcal disease;Rosenstein;N Engl J Med,2001

3. Australian Meningococcal Surveillance Programme annual report, 2015;Lahra;Commun Dis Intell Q Rep,2016

4. Short-term changes in the health state of children with group B meningococcal disease: a prospective, national cohort study;Kennedy;PLoS One,2017

5. Outcomes of invasive meningococcal serogroup B disease in children and adolescents (MOSAIC): a case-control study;Viner;Lancet Neurol,2012

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Past, present, and future policy considerations regarding meningococcal vaccination in the United States;Expert Review of Vaccines;2024-09-11

2. Immune interface interference vaccines: An evolution‐informed approach to anti‐bacterial vaccine design;Microbial Biotechnology;2024-03

3. Extensive Genetic Diversity and Epidemiological Patterns of Factor H-Binding Protein Variants among Neisseria meningitidis in China;Microorganisms;2024-02-27

4. Meningococcal factor H-binding protein: implications for disease susceptibility, virulence, and vaccines;Trends in Microbiology;2023-08

5. Serogroup B meningococcal vaccines from the public health perspective;The Lancet Infectious Diseases;2023-01